Published in Surgery Litigation and Law Weekly, January 29th, 2010
"RT was the primary treatment for gross disease in 70% of patients and for positive margin after resection in 30%. The prescribed dose was 50 to 60 Gy at 2.0 to 2.5 Gy per fraction. Surviving patients were followed for a median of 14 years. Tumor recurred at the primary site in 10%. There were no...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Surgery Litigation and Law Weekly